Form 4 for NVCR NovoCure Ltd
Accepted 2022-06-10 00:00:00 ET · period of report 2022-06-08 · accession 0001645113-22-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-10 | 2022-06-08 | NVCR | Hung David | Dir | A - Grant | $0.00 | +2,427 | 9,141 | +36% | $0 |
| D | 2022-06-10 | 2022-06-08 | NVCR | Hung David | Dir | A - Grant | $0.00 | +4,350 | 4,350 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Stock Units | 2022-06-08 | A | A | 2,427 | $0.00 | 9,141 | D | — | — | (F1) These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders. |
| 2 | Derivative | Options to Buy Ordinary Shares | 2022-06-08 | A | A | 4,350 | $0.00 | 4,350 | D | $77.25 · — to 2032-06-08 | 4,350 Ordinary Shares | (F2) Options to buy 4,350 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders. |